EMDIN, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 7.930
AS - Asia 4.033
EU - Europa 3.800
SA - Sud America 599
AF - Africa 234
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 16.607
Nazione #
US - Stati Uniti d'America 7.664
SG - Singapore 1.421
CN - Cina 1.155
SE - Svezia 821
IT - Italia 771
HK - Hong Kong 683
PL - Polonia 534
BR - Brasile 514
DE - Germania 458
GB - Regno Unito 254
BG - Bulgaria 212
CA - Canada 177
VN - Vietnam 175
UA - Ucraina 149
FI - Finlandia 130
RU - Federazione Russa 125
TR - Turchia 119
IN - India 116
KR - Corea 104
AT - Austria 92
CI - Costa d'Avorio 88
FR - Francia 75
SN - Senegal 57
CH - Svizzera 52
BD - Bangladesh 49
JP - Giappone 48
MX - Messico 45
IQ - Iraq 29
ES - Italia 24
ZA - Sudafrica 22
AR - Argentina 21
NG - Nigeria 20
NL - Olanda 19
BE - Belgio 17
ID - Indonesia 17
SA - Arabia Saudita 17
CZ - Repubblica Ceca 15
JO - Giordania 15
LT - Lituania 15
EC - Ecuador 13
PK - Pakistan 13
UZ - Uzbekistan 13
VE - Venezuela 13
KE - Kenya 12
MA - Marocco 11
JM - Giamaica 9
IE - Irlanda 8
UY - Uruguay 8
CL - Cile 7
EG - Egitto 7
IL - Israele 7
TT - Trinidad e Tobago 7
AL - Albania 6
CO - Colombia 6
HN - Honduras 6
HR - Croazia 6
NP - Nepal 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
IR - Iran 5
KG - Kirghizistan 5
PY - Paraguay 5
AU - Australia 4
AZ - Azerbaigian 4
BB - Barbados 4
BH - Bahrain 4
CR - Costa Rica 4
ET - Etiopia 4
EU - Europa 4
PA - Panama 4
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
BJ - Benin 2
BM - Bermuda 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
LY - Libia 2
MY - Malesia 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
Totale 16.592
Città #
Ashburn 836
Singapore 744
Woodbridge 724
Hong Kong 680
Santa Clara 665
Houston 587
Ann Arbor 563
Fairfield 521
Chandler 460
Dallas 374
Shanghai 304
Seattle 234
Beijing 223
Sofia 212
Cambridge 206
New York 199
Jacksonville 186
Wilmington 180
Boardman 165
Los Angeles 152
Serra 150
Milan 135
Ottawa 130
Munich 121
Seoul 104
Hefei 97
Lawrence 93
London 93
Princeton 93
Abidjan 88
Vienna 81
Medford 77
Nanjing 76
Izmir 74
Florence 68
Frankfurt am Main 58
Dakar 57
Buffalo 55
Dearborn 53
Bern 50
São Paulo 46
Des Moines 45
Turku 44
Pisa 43
Tokyo 43
Redondo Beach 42
Nanchang 34
Ho Chi Minh City 33
Jüchen 32
Bremen 31
Dong Ket 28
Hanoi 28
Istanbul 26
Warsaw 26
Düsseldorf 24
San Jose 24
Kent 23
Ogden 23
Lancaster 22
San Diego 22
Pune 21
Rome 21
Boulder 20
Lucca 20
Changsha 18
Brooklyn 17
Brussels 17
Fuzhou 17
Lagos 17
Kunming 16
Amman 15
Columbus 15
Guangzhou 15
Hebei 15
Redwood City 15
Chicago 14
San Francisco 14
Stockholm 14
Washington 14
Belo Horizonte 13
Denver 13
Helsinki 13
Hyderabad 13
Mexico City 13
Montreal 13
Tianjin 13
Brasília 12
Paris 12
Rio de Janeiro 12
Tashkent 12
Atlanta 11
Council Bluffs 11
Dhaka 11
Norwalk 11
Poplar 11
Shenyang 11
The Dalles 11
Baghdad 10
Orange 10
Orem 10
Totale 11.168
Nome #
Gamma-glutamyltransferase as a cardiovascular risk factor 664
Additive prognostic value of gamma-glutamyltransferase in coronary artery disease 219
Development of an electronic medical record for patient care in cardiology 200
A multiresolution transform for the analysis of cardiovascular time series 199
Additive prognostic value of gamma-glutamyltransferase in coronary artery disease 196
Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque 195
High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. 193
Spectral analysis of cardiovascular time series by the S-Transform 192
Effectiveness of adaptive filtering in cancelling the respiratory component from cardiovascular series 190
Bivariate spectral analysis of nonstationary cardiovascular variability series through cross Wigner distribution 185
Time-Dependent analysis of autonomic test: a method based on Wigner-Ville power spectral density estimation 181
An open system for managing long-term ECG recordings 180
New techniques to assess autonomic cardiovascular regulation 179
Alteration of lactate production during incremental excercise in myotonic dystrophy is not dependent by catecholamine increase 177
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values 174
Heart rate variability and myocardial infarction: acute and subacute phase 173
Estimation of the power spectral density in nonstationary cardiovascular time series: assessing the role of the time-frequency representations (TFR) 171
Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: A clinical, neuroradiological and virological response after treatment with risperidone 170
Modern diagnostic and therapeutical approach to cardiac AL amyloidosis and neuroendocrine model of heart failure: lessons from a clinical case. 169
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. 169
Altitude distress influence on cardiac function 168
Hypnosis effect on RR interval and blood pressure variability 167
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT 167
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure 165
Early assessment of heart rate variability is predictive of in-hospital death and major complications after acute myocardial infarction. , 96:361-368, 2004 162
Personality traits and heart rate variability predict long-term cardiac mortality after myocardial infarction 157
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 157
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 157
: The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases 156
Fractions of Gamma-Glutamyltransferase in healthy individuals, alcohol addicts and patients with hepatic disease 153
Beta-lipoprotein- and LDL-associated serum Gamma-glutamiyltransferase in patients with coronary atherosclerosis 153
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 153
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 152
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 151
Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. 149
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 149
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 148
Remote biosignal monitoring, display, online analysis and retrieval 148
Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity 147
ECG Devices interoperability in Hospital environment: clinical experience 145
Gamma-glutamiltransferasi e prognosi cardiovascolare: rivelazione e caratterizzazione di diverse forme di associazione dell’enzima nel plasma 144
Medical record system for cardiology and cardiac surgery 141
γ-glutamyltransferase and pathogenesis of cardiovascular diseases 141
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 141
Method of detecting and separating serum gamma-glutamyltransferase (GGT) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained. 140
Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability 140
Serum gamma-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption 138
Serum gamma-glutamyl transpeptidase: a prognostic marker in cardiovascular diseases 137
Postmortem cardiac magnetic resonance in sudden cardiac death 137
Serum γ-glutamiltransferase: A new factor in atherosclerotic plaque progression? 136
Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction 133
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 133
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 132
18-FDG PET for large vessel vasculitis diagnosis and follow-up 131
gamma-Glutamyltransferase activity in human atherosclerotic plaques-Biochemical similarities with the circulating enzyme 130
Gamma-glutamiltransferasi: rivelazione e quantificazione di diverse forme di associazione dell’enzima nel plasma 128
Post-mortem CMR in a model of sudden death due to myocardial ischemia: validation with connexin-43 128
Use of an electronic medical record in a department of cardiology 127
Emerging Biochemical Risk Markers of Stroke 126
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 126
When the heart is burning: Amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease 125
Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations 124
La gamma-glutamiltranspeptidasi sierica: un nuovo fattore nella progressione della placca aterosclerotica? 122
Caso clinico: cardiopatia in una portatrice di distrofia muscolare di Duchenne 122
Heart rate variability modified by altitude exposure 122
Plasma γ-glutamyltransferase fractions: diagnostic and prognostic predictive value 121
Cardiomiopatia dilatativa familiare associata a miopatia 120
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 120
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 114
Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study 113
Serum γ-glutamyltransferase: Linking together environmental pollution, redox equilibria and progression of atherosclerosis? 113
Forme molecolari della γ-glutammiltransferasi: Caratteristiche e biogenesi 112
null 108
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 107
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 107
Platelet activation, gamma-glutamyltransferase and stent restenosis - Comment on the article by Ulus et al 106
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 106
Lipids, glutathione and other key players in Redox cardiology 105
Unilateral Adrenal Hyperplasia in the Presence of a Reninoma in a Young Pregnant Woman 105
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy 104
null 103
Cardiac magnetic resonance in patients with muscular dystrophies 103
Rituximab as a novel treatment for heart failure: Evidence from a case series 103
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 100
A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis 100
Use of biomarkers to diagnose and manage cardiac amyloidosis 99
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 98
null 97
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 97
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 95
THE SIGNIFICANCE OF SERUM GAMMA-GLUTAMYLTRANSFERASE IN CARDIOVASCULAR DISEASES 92
Partial lipodystrophy and lmna p.R545h variant 92
null 91
[Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC)] 91
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 88
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 87
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 87
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 86
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 85
Biomarkers: monoclonal protein and indicators of cardiac damage. 84
Totale 14.123
Categoria #
all - tutte 47.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 0 85 64 70 46 45 97
2021/20221.093 10 54 18 102 208 138 50 33 64 49 93 274
2022/20231.743 236 306 126 133 173 197 28 133 294 1 110 6
2023/20241.663 121 108 127 64 133 222 73 37 21 526 101 130
2024/20254.357 49 155 68 201 461 479 317 186 379 488 450 1.124
2025/20262.980 419 566 464 493 598 428 12 0 0 0 0 0
Totale 16.817